At a glance
ClinicalIndex Comparison RecordN/ACompleted· 106 enrolled
Drug / intervention
Sit Less, Interact, Move More (SLIMM)behavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Sit Less, Interact, Move More (SLIMM) Intervention for Sedentary Behavior in Chronic Kidney Disease (CKD)
In Brief
A clinical study evaluating Sit Less, Interact, Move More (SLIMM) for Chronic Kidney Disease. Completed, enrolled 106 participants across 1 site.
Detailed Summary
Sedentary behavior is engaging in activities in the seated or lying position that barely raise the energy expenditure level and has emerged as an important risk factor for obesity, diabetes, cardiovascular disease and mortality. The primary hypothesis is that the Sit Less, Interact, Move More (SLIMM) intervention in Chronic Kidney Disease (CKD) will be effective in decreasing sedentary duration by increasing casual walking duration and thereby, increase physical activity energy expenditure.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Kidney Disease
CountriesUnited States
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedNov 2016
Enrollment StartDec 2016
Primary CompletionSep 2019
TodayJul 2026
First PostedNov 21, 2016
Enrollment StartDec 1, 2016
Primary CompletionSep 12, 2019
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 9.6 years ago
Interventions
Sit Less, Interact, Move More (SLIMM)behavioral